Article Details

Eiger BioPharmaceuticals Announces Presentation of Positive Phase 2 Results of Avexitide in ...

Retrieved on: 2021-06-28 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Eiger BioPharmaceuticals Announces Presentation of Positive Phase 2 Results of Avexitide in .... View article details on hiswai:

Excerpt

PALO ALTO, Calif., June 28, 2021 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up